The latest draft of 21st Century Cures legislation released Tuesday (May 19) seeks $90 million over five years in additional funding for FDA for three specific provisions that require: the qualification of biomarkers and other drug development tools; collection of evidence from clinical experience using the Sentinel System; and grants for studying and recommending improvements to the process of continuous manufacturing of drugs and biologic products. The latest draft comes a day ahead of a scheduled markup by the full...